Your session is about to expire
← Back to Search
Simplified Language for Autism (PALS Trial)
N/A
Recruiting
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up single assessment; total duration less than 10 minutes
Awards & highlights
PALS Trial Summary
This trial will examine how single-word and telegraphic simplification affect language processing and word learning in young children with ASD.
Who is the study for?
This trial is for young children aged 1-4 who have been diagnosed with autism spectrum disorder or are suspected to have it, confirmed through ADOS-2. They must primarily speak English. Children with genetic conditions like Down syndrome, brain injuries, cerebral palsy, or uncorrected vision/hearing issues cannot participate.Check my eligibility
What is being tested?
The study is testing how simplifying language in different ways affects the ability of young autistic children to process and learn new words. It compares full sentences to single-word and short phrases (telegraphic speech) to see which supports better understanding and learning.See study design
What are the potential side effects?
Since this trial involves linguistic intervention rather than medication, there aren't typical side effects as seen in drug trials. However, variations in language exposure could potentially influence a child's natural language development patterns.
PALS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ single assessment; total duration less than 10 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~single assessment; total duration less than 10 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Gaze location on Looking-While-Listening (LWL) tasks
Secondary outcome measures
Gaze location in Teaching Phase of Study 2b (Fast Mapping)
PALS Trial Design
1Treatment groups
Experimental Treatment
Group I: Utterance TypeExperimental Treatment1 Intervention
This study uses a within-participant experimental manipulation. All participants will be exposed to all utterance types (across trials).
Find a Location
Who is running the clinical trial?
Michigan State UniversityLead Sponsor
185 Previous Clinical Trials
601,874 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
1,680 Patients Enrolled for Autism Spectrum Disorder
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,367 Total Patients Enrolled
10 Trials studying Autism Spectrum Disorder
892 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have vision or hearing problems that haven’t been corrected.I am between 1 and 4 years old.I have a diagnosed genetic condition like Down syndrome.
Research Study Groups:
This trial has the following groups:- Group 1: Utterance Type
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the eligibility for this experiment necessitate a minimum age requirement of 60 or less?
"This clinical experiment necessitates that participants must be within a certain age range; from one year of age up to four. Additionally, there are various other treatments available for minors (224) and seniors (42)."
Answered by AI
Are there still opportunities for patients to enroll in this experiment?
"At this time, the clinical trial specified is not currently accepting applications. Per information on clinicaltrials.gov, the original posting date was February 1st 2023 and it last updated January 31st 2023. However, there are 267 other trials searching for candidates right now."
Answered by AI
Could I potentially be a part of this research endeavor?
"This clinical trial is accepting 104 individuals with a diagnosis of autism spectrum disorder confirmed by ADOS-2 and who are 1 to 4 years old. Furthermore, these applicants must primarily speak English."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger